Related Experiment Video
Updated: Nov 27, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
14-3-3σ and Its Modulators in Cancer
Ghazi Aljabal1, Beow Keat Yap1
1School of Pharmaceutical Sciences, Universiti Sains Malaysia, Gelugor 11800, Penang, Malaysia.
Abstract:
14-3-3σ is an acidic homodimer protein with more than one hundred different protein partners associated with oncogenic signaling and cell cycle regulation. This review aims to highlight the crucial role of 14-3-3σ in controlling tumor growth and apoptosis and provide a detailed discussion on the structure-activity relationship and binding interactions of the most recent 14-3-3σ protein-protein interaction (PPI) modulators reported to date, which has not been reviewed previously. This includes the new fusicoccanes stabilizers (FC-NAc, DP-005), fragment stabilizers (TCF521-123, TCF521-129, AZ-003, AZ-008), phosphate-based inhibitors (IMP, PLP), peptide inhibitors (2a-d), as well as inhibitors from natural sources (85531185, 95911592). Additionally, this review will also include the discussions of the recent efforts by a different group of researchers for understanding the binding mechanisms of existing 14-3-3σ PPI modulators. The strategies and state-of-the-art techniques applied by various group of researchers in the discovery of a different chemical class of 14-3-3σ modulators for cancer are also briefly discussed in this review, which can be used as a guide in the development of new 14-3-3σ modulators in the near future.
Insights
14-3-3σ protein is vital for controlling tumor growth and apoptosis. This review details recent protein-protein interaction modulators, offering insights for developing new cancer therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- 14-3-3σ is an acidic homodimer protein involved in oncogenic signaling and cell cycle regulation.
- It interacts with over one hundred protein partners, influencing critical cellular processes.
Purpose of the Study:
- To review the role of 14-3-3σ in tumor growth and apoptosis.
- To discuss structure-activity relationships and binding interactions of recent 14-3-3σ protein-protein interaction (PPI) modulators.
- To explore binding mechanisms and discovery strategies for novel 14-3-3σ modulators.
Main Methods:
- Literature review of recent studies on 14-3-3σ modulators.
- Analysis of structure-activity relationships and binding interactions.
- Discussion of various chemical classes of modulators and discovery techniques.
Main Results:
- Recent modulators include fusicoccanes, fragment stabilizers, phosphate-based inhibitors, peptide inhibitors, and natural product inhibitors.
- Insights into binding mechanisms of existing modulators have been elucidated.
- Various strategies and techniques for discovering new 14-3-3σ modulators are presented.
Conclusions:
- 14-3-3σ plays a critical role in cancer, making it a promising therapeutic target.
- Understanding PPI modulators is key to developing targeted cancer therapies.
- This review serves as a guide for future development of 14-3-3σ modulators for cancer treatment.
More Related Videos
11:19Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Negative Regulator Molecules
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....